Retatrutide

Triple GIP/GLP-1/glucagon receptor agonist

Retatrutide (LY3437943) is an investigational peptide studied as a triple agonist of GIP, GLP-1, and glucagon receptors in metabolic research models.

Research Applications

Triple incretin receptor activation

Advanced metabolic research

Energy expenditure studies

Multi-pathway glucose regulation

For Research Use Only — Not for Human Consumption

Select Size

Price excl. VAT

24,00 €

14 in stock

VAT (20%) × 1+4,80 €

Total incl. VAT28,80 €

RETA-2MG

Store at −20 °C.